Inventor
Bömer Ulf
DE62 patents
⚠️ This page may combine multiple inventors who share the name “Bömer Ulf”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
21 patentsUS10308634B2Jun 4, 2019
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG17 citations93
US9951086B2Apr 24, 2018
Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments
Bayer Pharma AG21 citations84
US10729680B2Aug 4, 2020
5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG10 citations83
US10793545B2Oct 6, 2020
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG7 citations82
US9540392B2Jan 10, 2017
Thienopyrimidines
Bayer Pharma AG2 citations72
US9409889B2Aug 9, 2016
Amino-substituted imidazopyridazines
Bayer Pharma AG3 citations72
US12006304B2Jun 11, 2024
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
Bayer Pharma AG1 citations71
US12006303B2Jun 11, 2024
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugs
Bayer Pharma AG1 citations71
US10435396B2Oct 8, 2019
2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs
Bayer Pharma AG7 citations71
US9963464B2May 8, 2018
Macrocyclic compounds
Bayer Pharma AG2 citations71
US9670202B2Jun 6, 2017
Substituted triazolopyridines
Bayer Pharma AG2 citations62
US12559473B2Feb 24, 2026
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
Bayer Pharma AG0 citations61
US9790189B2Oct 17, 2017
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
Bayer Pharma AG1 citations52
US9499492B2Nov 22, 2016
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
Bayer Pharma AG1 citations52
US9877954B2Jan 30, 2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US9670161B2Jun 6, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations51
US9650340B2May 16, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US10894784B2Jan 19, 2021
Heteroarylbenzimidazole compounds
Bayer Pharma AG0 citations48
US10214545B2Feb 26, 2019
Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
Bayer Pharma AG0 citations41
US9783543B2Oct 10, 2017
Aminoimidazopyridazines
Bayer Pharma AG0 citations41
US9745304B2Aug 29, 2017
Amidoimidazopyridazines as MKNK-1 kinase inhibitors
Bayer Pharma AG0 citations41
BAYER IP GMBH
6 patentsUS9320737B2Apr 26, 2016
Substituted imidazopyridazines
BAYER IP GMBH27 citations93
US9206184B2Dec 8, 2015
Disubstituted benzothienyl-pyrrolotriazines and uses thereof
BAYER IP GMBH4 citations69
US9370517B2Jun 21, 2016
Substituted pyrazolopyrimidines as Akt kinase inhibitors
BAYER IP GMBH2 citations61
US9962389B2May 8, 2018
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
BAYER IP GMBH0 citations51
US9604989B2Mar 28, 2017
Imidazopyridazines as Akt kinase inhibitors
BAYER IP GMBH0 citations51
US9777004B2Oct 3, 2017
Amino-substituted imidazopyridazines
BAYER IP GMBH0 citations41
BAYER AG
5 patentsUS11339157B1May 24, 2022
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
BAYER AG2 citations69
US11998539B2Jun 4, 2024
Substituted aminoquinolones as DGKalpha inhibitors for immune activation
BAYER AG1 citations59
US12478621B2Nov 25, 2025
Substituted aminoquinolones as dgkalpha inhibitors for immune activation
BAYER AG0 citations58
US12227501B2Feb 18, 2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors
BAYER AG1 citations58
US12565496B2Mar 3, 2026
Substituted 1H-pyrrolo[3,2-b]pyridine compounds and methods of use thereof
BAYER AG0 citations43
Lücking Ulrich
4 patentsUS9133171B2Sep 15, 2015
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
Lücking Ulrich5 citations72
US9669034B2Jun 6, 2017
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
Lücking Ulrich2 citations71
US8916557B2Dec 23, 2014
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
Lücking Ulrich4 citations71
US9108926B2Aug 18, 2015
Disubstituted 5-fluoro-pyrimidines
Lücking Ulrich1 citations51
EIS KNUT
3 patentsLIU NINGSHU
3 patentsUS9278925B2Mar 8, 2016
Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
LIU NINGSHU3 citations71
US9000026B2Apr 7, 2015
Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
LIU NINGSHU2 citations61
US9212140B2Dec 15, 2015
(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment
LIU NINGSHU0 citations49
REHWINKEL HARTMUT
1 patentBADER BENJAMIN
1 patentBärfacker Lars
1 patentSCOTT WILLIAM JOHNSTON
1 patentINCE STUART
1 patentVENNEMANN MATTHIAS
1 patentKOPPITZ MARCUS
1 patentBAYER ANIMAL HEALTH GMBH
1 patentShowing the top 50 of 62 patents by PatentIndex Score.